Brand: Lilly
Product Code: 539
Availability: In Stock
Ex Tax: £12.99

In our steroids store you can buy short insulin Humalog (Humalog), manufactured by Lilly France.

Important: The price is per 1 ml ampoule. When ordering this drug, the time of shipment is shifted by 1-2 days. Thank you for your understanding.

The composition of Insulinum Lispro: solution for intravenous and subcutaneous administration - 1 ml active ingredient: insulin lispro 100 IU excipients: glycerol (glycerin) - 16 mg; m-cresol - 3.15 mg; zinc oxide - q.s. (for the content of Zn2 + - 0,0197 mg); sodium hydrophosphate heptahydrate - 1.88 mg; hydrochloric acid solution of 10% and / or sodium hydroxide solution of 10% - q.s. up to pH 7–8; water for injection q.s. up to 1 ml Pharmachologic effect: hypoglycemic. Dosage and administration:

P / c in the form of injections or prolonged p / c infusion using an insulin pump.

The dose of the drug Humalog is determined by the doctor individually, depending on the concentration of glucose in the blood. The mode of administration of insulin is individual. The drug Humalog can be administered shortly before a meal, if necessary, it can be administered shortly after a meal. The temperature of the administered drug should be at room temperature.

If necessary (ketoacidosis, acute diseases, the period between operations or the postoperative period), Humalog can also be administered intravenously. P / c should be entered in the shoulder, thigh, buttocks or abdomen. Injection sites should be alternated in such a way that the same place should not be used more often than about 1 time per month.

When n / a administration of the drug Humalog, care must be taken to avoid getting the drug into a blood vessel. After the injection should not massage the injection site. The patient must be trained in the proper technique of the injection.

Instructions for the administration of the drug Humalog Preparation for the introduction of

The solution of the drug Humalog should be transparent and colorless. Do not use the drug solution Humalog, if it turns out to be cloudy, thickened, poorly colored or visually detectable solid particles. When inserting the cartridge into a pen, attaching a needle and performing an insulin injection, follow the manufacturer's instructions that are attached to each pen.


1. Wash your hands.

2. Select injection site.

3. Wipe the skin at the injection site.

4. Remove the cap from the needle.

5. Fix the skin by pulling it or big crease. Insert the needle according to the instructions for using the syringe handle.

6. Press the button.

7. Remove the needle and gently press the injection site with a cotton swab for a few seconds. Do not rub the injection site.

8. Using a protective needle cap, unscrew the needle and dispose of it.

9. Alternate injection sites so that the same place should not be used more than once a month.

< p> For the drug Humalog in syringe pen KvikPen. Before administering insulin, you should familiarize yourself with the QuickPen syringe pen.

B / in insulin administration. In / in the injection of the drug Humalog must be carried out in accordance with the usual clinical practice in / in the injection, for example, in / in the bolus or using the system for infusions. This often requires monitoring the concentration of glucose in the blood. Systems for infusions with concentrations from 0.1 to 1.0 IU / ml insulin lispro in 0.9% sodium chloride or 5% dextrose are stable at room temperature for 48 hours.

insulin infusion with an insulin pump. For infusion of the drug Humalog, you can use Minimed and Disetronic pumps for insulin infusion. It is necessary to strictly follow the instructions attached to the pump. The infusion system is changed every 48 hours. When connecting the infusion system, the asepsis rules are followed. In the case of a hypoglycemic episode, the infusion is stopped until the episode resolves. If there is a very low concentration of glucose in the blood, then this should be reported to the doctor and provide for a decrease or termination of insulin infusion. A pump malfunction or a clogged infusion system can lead to a rapid rise in glucose concentration. In case of suspected violation of insulin delivery, it is necessary to follow the instructions and inform the doctor if necessary. When using a pump, Humalog should not be mixed with other insulins.

Guidelines for using the syringe pen QuicPen

Introduction. QuickPen syringe pen is easy to use. It is a device for administering insulin (“insulin syringe pen”) containing 3 ml (300 U) of an insulin preparation with an activity of 100 IU / ml. You can enter from 1 to 60 IU of insulin per injection. You can set the dose to within one unit. If too many units are installed, you can correct the dose without losing insulin.

Prepare the QuickPen syringe pen. You should read and follow the instructions set forth in the instructions for use of the drug. You must check the label on the pen before each injection to make sure that the expiration date of the drug has not expired, and the patient uses the correct type of insulin; Do not remove the label from the pen.

Note. The color of the QuickPen в„ў syringe injection pen button corresponds to the color of the strip on the syringe pen label and depends on the type of insulin. In this manual, the dose button is grayed out. The blue color of the body of QuickPen в„ў syringe pens indicates that it is intended for use with Humalogue preparations.

The QuickPen syringe grip is recommended for use with Becton, Dickinson and Company (BD) needles for syringe pens

Before using the syringe pen, make sure that the needle is fully attached to the syringe pen.

In the future, the following rules should be observed.

Administer the required dose

Follow the aseptic and antiseptic rules recommended by the attending physician.

Ensure that the patient has injected the required dose by pressing and holding the dose button, and slowly count to 5 before the needle is removed. If insulin drips from the needle, the patient most likely did not hold the needle under the skin for long enough. Having a drop of insulin at the needle tip is normal, it will not affect the dose.

The syringe pen will not allow the patient to collect a dose that exceeds the number of insulin units left in the cartridge.

If there is doubts that a full dose has been administered should not be given another one. You should contact your doctor for help.

If the required dose for injection exceeds the number of units remaining in the cartridge, you can enter the remaining amount of insulin in this pen and then use a new pen to complete the required dose, or Inject the required dose using a new pen.

Do not attempt to inject insulin by turning the dose button. The patient will not receive insulin if the dose button is rotated. You must press the dose injection button in a straight line in order to receive the insulin dose.

Do not try to change the insulin dose during the injection.

The used needle should be disposed of according to local disposal requirements medical waste.

It is necessary to remove the needle after completing each injection.

Storage and disposal p>

Do not store the syringe pen attached to it needle. If the needle is left attached, insulin can flow out of the syringe pen, or dry inside the needle, causing clogging of the needle, or air bubbles can form inside the cartridge.

The syringe pen that is not in use, should be stored in a refrigerator at a temperature of 2 to 8 В° C. Do not use a pen syringe if it has been frozen.

The pen syringe currently used should be stored at a temperature not exceeding 30 В° C in a place protected from heat and light.

Keep a pen syringe out of reach of children.

Dispose of used needles in closed-seal containers protected from puncturing (for example, in containers for biohazardous substances or wastes) or as recommended by your doctor.

Dispose of used syringe pens without needles attached to them in accordance recommendations of the treating physician.

Do not be recycled filled sharps container. The patient needs to ask his doctor about possible disposal of filled containers for sharps available in a particular region.

1. Prepare QuickPen syringe pen.

Pull the syringe pen cap to remove it. Do not rotate cap. Do not remove the label from the pen. Ensure that insulin is tested for the type of insulin; expiration date; appearance.

Take a new needle. Remove the paper sticker from the outer needle cap. Use a swab moistened with alcohol to wipe the rubber disc on the end of the cartridge holder. Put on the needle, which is in the cap, directly along the axis of the syringe-pen. Screw the needle in until it is completely attached.

2. Check QuicPen в„ў syringe pens for insulin flow. Each time you should check insulin flow. Insulin delivery from the syringe pen should be checked before each injection before an insulin trickle appears to ensure that the syringe pen is ready for a dose.

If you do not check the insulin flow before the trickle appears, you can get too little or too much insulin.

3. Dosing.

Fix the skin by pulling it together or gathering it in a large fold. Rotate the dose button to the number of units needed for the injection. Introduce the needle, using the injection technique recommended by your doctor. Put your thumb on the dose button and press firmly until it stops. For the full dose, hold the dose button and slowly count to 5.

Remove the needle and put on a protective cap on the needle, gently press the injection site with a cotton swab for a few seconds. Do not rub the injection site. If insulin drips from the needle, the patient most likely did not hold the needle under the skin for long enough. Having a drop of insulin at the tip of the needle is normal, it will not affect the dose.

Using the protective cap of the needle, turn off the needle and dispose of it.

Even numbers are printed in the dose indicator window as numbers, odd numbers are printed as straight lines between even numbers.

Note: the pen does not allow the patient to set the number of units greater than the number of units left in the pen. If there is no certainty that the full dose is injected, do not introduce another one.

Release form

Solution for intravenous and subcutaneous administration, 100 IU / ml. In cartridges of 3 ml of the drug in the cartridge. On 5 cartridges in the blister. One blister in a carton pack.

Syringe pens QuickPen: 3 ml of the drug per cartridge, built-in syringe pen KvikPen в„ў. On five syringe pens KvikPen in a pack cardboard.

Package 3ml 100ME/ml
Substance Insulin

Write a review

Note: HTML is not translated!